Global CROs Services Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global CROs Services Market Research Report 2024
Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities.
According to Mr Accuracy reports new survey, global CROs Services market is projected to reach US$ 143900 million in 2029, increasing from US$ 76000 million in 2022, with the CAGR of 9.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CROs Services market research.
The contract research organizations (CRO) services market is experiencing significant growth due to various factors. Factors such as increasing outsourcing of clinical trials by pharmaceutical and biotechnology companies, rising demand for specialized services, and the need for cost-effective drug development are driving market expansion. CROs offer a wide range of services, including clinical trial management, data management, regulatory affairs, and pharmacovigilance, providing expertise and operational support to clients. Additionally, advancements in technology and the growing complexity of clinical research further contribute to market growth. Moreover, the global expansion of clinical trials and the rising focus on personalized medicine fuel the demand for CRO services. However, factors such as stringent regulatory requirements and challenges in data quality management may pose hurdles to market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CROs Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Charles River Laboratories International Inc (CRL)
Hangzhou Tigermed
Clinipace
PSI CRO
Pierrel Research
Segment by Type
Full-Service CRO
Functional Service Provision CRO
Pre-clinical
Clinical I-Ⅲ
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The CROs Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global CROs Services market is projected to reach US$ 143900 million in 2029, increasing from US$ 76000 million in 2022, with the CAGR of 9.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CROs Services market research.
The contract research organizations (CRO) services market is experiencing significant growth due to various factors. Factors such as increasing outsourcing of clinical trials by pharmaceutical and biotechnology companies, rising demand for specialized services, and the need for cost-effective drug development are driving market expansion. CROs offer a wide range of services, including clinical trial management, data management, regulatory affairs, and pharmacovigilance, providing expertise and operational support to clients. Additionally, advancements in technology and the growing complexity of clinical research further contribute to market growth. Moreover, the global expansion of clinical trials and the rising focus on personalized medicine fuel the demand for CRO services. However, factors such as stringent regulatory requirements and challenges in data quality management may pose hurdles to market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CROs Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Charles River Laboratories International Inc (CRL)
Hangzhou Tigermed
Clinipace
PSI CRO
Pierrel Research
Segment by Type
Full-Service CRO
Functional Service Provision CRO
Segment by Application
Pre-clinical
Clinical I-Ⅲ
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The CROs Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source